跳转到主要内容
搜索

战略领导力

注册

最新资源

精选资源

Upcoming strategic leadership webinars

Popular resources

在以下活动中与我们的专家会面

会议

Redefining Every Stage of Investment (RESI) Seed to Exit

September 22 - 23, 2026 – Westin Copley Place | Boston, MA
会议

ISSX 27th North American Meeting

October 11 - 14, 2026 – San Francisco, CA
会议

ACoP 2026

2026 年 10 月 11 - 14 日

All Strategic Leadership resources

Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development

Certara Services, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Publication

A glimpse into the future of model-informed drug discovery and development

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Oncology/Hematology, Pharmacometrics, Therapeutic Specialties, Publication

The Road to First-in-Human: Model-Informed Decisions from Discovery to First Dose

Certara Services, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

MBMA data curation: How AI and expert meta-analysts get it right, fast

Certara Services, Clinical Trials, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - MBMA, Blog

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Model Informed Drug Development, On-Demand Webinar

Important drug development questions that model-based meta-analysis answers

Certara Services, Clinical Pharmacology, Drug Development Support, Model Informed Drug Development, Modeling and Simulation - MBMA, Blog

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Publication

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Certara Services, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Conference

Enhancing clinical trials with real-world evidence in pregnancy research

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Real World Evidence, Therapeutic Specialties, Blog

Building IND-Ready and Investor-Ready Development Programs

Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, New Approach Methodologies (NAMs), On-Demand Webinar

Beyond compliance: What ICH M15 means for the future of drug development

Certara Services, Clinical Pharmacology, Drug Development, ICH M15, Model Informed Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog

Certainty US 2026 recap: Advancing model-informed drug development right from the start

AI & Machine Learning, Data Standards, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Blog
订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。


沪ICP备2022021526号
Powered by Translations.com GlobalLink Web Software